SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+9.88%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$389M
AUM Growth
+$389M
(+5.4%)
Cap. Flow
-$13.4M
Cap. Flow
% of AUM
-3.45%
Top 10 Holdings %
Top 10 Hldgs %
67.8%
Holding
27
New
3
Increased
15
Reduced
6
Closed
3
Top Buys
| 1 |
Biogen
BIIB
|
$14.3M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$8.04M |
| 3 |
STJ
St Jude Medical
STJ
|
$7.08M |
| 4 |
McKesson
MCK
|
$6.37M |
| 5 |
Baxter International
BAX
|
$3.75M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$16.3M |
| 2 |
Johnson & Johnson
JNJ
|
$12M |
| 3 |
Cardinal Health
CAH
|
$10.2M |
| 4 |
Stryker
SYK
|
$9.14M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
$7.77M |
Sector Composition
| 1 | Healthcare | 86.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Baxter International
BAX
$12.7B
| $35.8M | 9.19% | 937,600 +98,200 | +12% | +$3.75M |
|
|
BXLT
2
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $35.8M | 9.19% | 916,000 +23,800 | +3% | +$929K |
|
3
Eli Lilly
LLY
$657B
| $34.2M | 8.8% | 406,390 +40,443 | +11% | +$3.41M |
|
|
4
Johnson & Johnson
JNJ
$427B
| $31.1M | 8% | 302,930 -117,170 | -28% | -$12M |
|
5
Boston Scientific
BSX
$156B
| $25.9M | 6.65% | 1,403,360 -328,540 | -19% | -$6.06M |
|
|
6
Biogen
BIIB
$19.4B
| $23.1M | 5.93% | 75,300 +46,700 | +163% | +$14.3M |
|
7
Ironwood Pharmaceuticals
IRWD
$214M
| $22.9M | 5.88% | 1,974,421 +148,230 | +8% | +$1.72M |
|
8
Revvity
RVTY
$10.5B
| $21.8M | 5.6% | 406,630 +16,270 | +4% | +$872K |
|
9
Integra LifeSciences
IART
$1.18B
| $16.8M | 4.31% | 247,433 +28,970 | +13% | +$1.96M |
|
10
Bio-Rad Laboratories Class A
BIO
$8.06B
| $16.6M | 4.27% | 119,830 +4,730 | +4% | +$656K |
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $14.7M | 3.77% | 116,633 +9,570 | +9% | +$1.2M |
|
|
12
Bristol-Myers Squibb
BMY
$96B
| $14.6M | 3.76% | 212,490 -236,310 | -53% | -$16.3M |
|
13
Cigna
CI
$80.3B
| $13.2M | 3.38% | 90,020 +3,420 | +4% | +$500K |
|
14
Owens & Minor
OMI
$378M
| $12M | 3.09% | 334,302 +13,550 | +4% | +$488K |
|
15
Masimo
MASI
$7.59B
| $11.9M | 3.07% | 287,863 -10,160 | -3% | -$422K |
|
|
16
Cardinal Health
CAH
$35.5B
| $10.1M | 2.6% | 113,430 -114,470 | -50% | -$10.2M |
|
|
MDVN
17
DELISTED
MEDIVATION, INC.
MDVN
| $8.04M | 2.07% | +166,353 | New | +$8.04M |
|
18
Tenet Healthcare
THC
$16.3B
| $7.82M | 2.01% | 258,090 -28,310 | -10% | -$858K |
|
|
WCG
19
DELISTED
Wellcare Health Plans, Inc.
WCG
| $7.81M | 2.01% | 99,865 +13,320 | +15% | +$1.04M |
|
|
STJ
20
DELISTED
St Jude Medical
STJ
| $7.08M | 1.82% | +114,570 | New | +$7.08M |
|
|
21
McKesson
MCK
$85.4B
| $6.37M | 1.64% | +32,300 | New | +$6.37M |
|
|
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $6.3M | 1.62% | 424,536 +73,616 | +21% | +$1.09M |
|
23
Community Health Systems
CYH
$387M
| $4.88M | 1.25% | 183,970 +7,370 | +4% | +$196K |
|
|
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $458K | 0.12% | 76,000 +1,300 | +2% | +$7.83K |
|
|
25
Stryker
SYK
$150B
| – | – | -97,083 | Closed | -$9.14M |
|